Solutions
You will receive an email with a link to the webinar
Biotherapies
Join us for this webinar with Dr. Colleen Delaney, Affiliate Investigator in the Clinical Research Division at Fred Hutch Cancer Center.
The purpose of this session is to talk about the decline in the use of umbilical cord blood (UCB) as a primary stem cell source for hematopoietic transplants.
Dr. Delaney will discuss best practices for improving UCB donor selection and increasing better quality and larger amounts of starting material products.
Watch now!
Watch now
Fill out the form to access the on-demand recording
Recorded Oct 23, 2018
WellSky only wants to send you the information you are interested in. Please fill out the form below to choose the emails you want to receive. We only send emails to subscribers. If you are an existing customer, you will continue to receive certain notifications.
Dr. Colleen Delaney is pioneering methods to make umbilical cord blood transplants more available and successful worldwide. Because it does not need to be as closely matched to the patient as bone marrow, cord blood offers an option to those thousands of blood cancer patients every year who can’t find a matched adult donor. Dr. Delaney developed a breakthrough method for multiplying the small number of stem and progenitor cells in each cord blood unit hundreds of times over in the lab. Her primary research focus is on developing these multiplied cells for use in the clinic. Her goal is to develop therapies that protect patients from severe side effects after cord blood transplant or intensive chemotherapy. Dr. Delaney was the founding director of the Hutch’s Cord Blood Program.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
WellSky is a technology company that delivers software and services to transform an ever-growing range of care services worldwide. Building on a history of excellence and a reputation for quality, WellSky – formerly Mediware Information Systems and Kinnser Software – empowers providers to provide exceptional care, improve operational efficiency, reduce cost, and meet the challenges of their rapidly changing industries.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.